Anti-HIV activity profile of a novel CCR5 inhibitor, AMD887, in combination with the CXCR4 inhibitor AMD070

Dominique Schols; Kurt Vermeire; Sigrid Hatse; Katrien Princen; De Clercq Erik; Gary Calandra; Simon P. Fricker; Kim L. Nelson; J Labrecque; David Bogucki; Ya-Shi Zhou; Renato T. Skerlj; Gary Bridger

Back

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2004

In vitro anti-HIV activity profile of AMD887, a novel CCR5 antagonist, in combination with the CXCR4 inhibitor AMD070

Dominique Schols, Kurt Vermeire, Sigrid Hatse, Katrien Princen, De Clercq Erik, Gary Calandra, Simon P. Fricker, Kim L. Nelson, J Labrecque, David Bogucki, Ya-Shi Zhou, Renato T. Skerlj, Gary Bridger

Article2003

Anti-HIV activity profile of AMD070, an orally bioavailable CXCR4 antagonist

Dominique Schols, Sandra Claes, Sigrid Hatse, Katrien Princen, Kurt Vermeire, De Clercq Erik, Renato T. Skerlj, Gary Bridger, Gary Calandra

Article2003

The anti-HIV activity of the CXCR4 inhibitor AMD3100 is independent of the CXCR4/HIV coreceptor level

Katrien Princen, Sigrid Hatse, Kurt Vermeire, Gary Bridger, Renato T. Skerlj, De Clercq Erik, Dominique Schols

Article2004

Establishment of a novel CCR5 and CXCR4 expressing CD4+ cell line which is highly sensitive to HIV and suitable for high-throughput evaluation of CCR5 and CXCR4 antagonists

Katrien Princen, Sigrid Hatse, Kurt Vermeire, De Clercq Erik, Dominique Schols

Article2004

CADA, a novel CD4-targeted HIV inhibitor, is synergistic with various anti-HIV drugs in vitro

Kurt Vermeire, Katrien Princen, Sigrid Hatse, De Clercq Erik, K Dey, Thomas W. Bell, Dominique Schols